AIMC Topic: Drug Discovery

Clear Filters Showing 1341 to 1350 of 1568 articles

Role of Artificial Intelligence in Drug Discovery and Target Identification in Cancer.

Current drug delivery
Drug discovery and development (DDD) is a highly complex process that necessitates precise monitoring and extensive data analysis at each stage. Furthermore, the DDD process is both timeconsuming and costly. To tackle these concerns, artificial intel...

Graph-DTI: A New Model for Drug-target Interaction Prediction Based on Heterogenous Network Graph Embedding.

Current computer-aided drug design
BACKGROUND: In this study, we aimed to develop a new end-to-end learning model called Graph-Drug-Target Interaction (DTI), which integrates various types of information in the heterogeneous network data, and to explore automatic learning of the topol...

Exploring Scoring Function Space: Developing Computational Models for Drug Discovery.

Current medicinal chemistry
BACKGROUND: The idea of scoring function space established a systems-level approach to address the development of models to predict the affinity of drug molecules by those interested in drug discovery.

DrugGen: a database of de novo-generated molecular binders for specified target proteins.

Database : the journal of biological databases and curation
De novo molecular generation is a promising approach to drug discovery, building novel molecules from the scratch that can bind the target proteins specifically. With the increasing availability of machine learning algorithms and computational power,...

Attention is all you need: utilizing attention in AI-enabled drug discovery.

Briefings in bioinformatics
Recently, attention mechanism and derived models have gained significant traction in drug development due to their outstanding performance and interpretability in handling complex data structures. This review offers an in-depth exploration of the pri...

BatmanNet: bi-branch masked graph transformer autoencoder for molecular representation.

Briefings in bioinformatics
Although substantial efforts have been made using graph neural networks (GNNs) for artificial intelligence (AI)-driven drug discovery, effective molecular representation learning remains an open challenge, especially in the case of insufficient label...